Beijing Hotgen Biotech Co., Ltd. stated on the interactive platform that the company has established the 'X-Gen AI New Drug Discovery and Design Research Center' at the Daxing Biomedical Industry Base in Zhongguancun Science and Technology Park, Beijing. The core members of the team come from top universities and scientific research institutions at home and abroad. The company has cooperated with Hangzhou Huijian Technology, fully integrating the original technology and core R&D advantages of Hotgen Biotech in glycobiology and Huijian Technology in high-throughput clinical mass spectrometry and proteomics technology fields. The two parties will focus on tumor diagnosis application scenarios through complementary advantages and in-depth cooperation, and jointly devote themselves to the research and development of new generation mass spectrometry diagnostic products.